| Record ID | harvard_bibliographic_metadata/ab.bib.13.20150123.full.mrc:432306033:1245 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.13.20150123.full.mrc:432306033:1245?format=raw |
LEADER: 01245nam a2200313 a 4500
001 013378394-4
005 20121013021256.0
006 m d f
008 120926s2012 dcu o f000 0 eng c
035 0 $aocn811142449
035 $a(FDLP)ocn811142449
040 $aGPO$cGPO
042 $apcc
043 $an-us---
074 $a0497-D-03 (online)
086 0 $aHE 20.408:P 84
245 00 $aPharmacologic guidelines for treating individuals with post-traumatic stress disorder and co-occurring opioid use disorders$h[electronic resource].
260 $a[Washington, D.C.] :$bU.S. Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration,$c[2012]
300 $a1 online resource (13 p.)
490 1 $aHHS Publication ;$vno. SMA-12-4688
500 $aTitle from title screen (viewed on Sept. 26, 2012).
504 $aIncludes bibliographical references (p. 7-10).
650 0 $aPharmacology$zUnited States.
650 0 $aPost-traumatic stress disorder$xTreatment.
650 0 $aOpioid abuse$xTreatment$zUnited States.
710 1 $aUnited States.$bSubstance Abuse and Mental Health Services Administration.
830 0 $aHHS publication ;$vno. SMA-12-4688.
988 $a20121013
906 $0OCLC